DVA
DAVITA INC.
NYSE · Healthcare · Medical - Care Facilities · US
$188.75
+3.61%Year over year
Reported trailing growth
- Revenue
- +6.4%
- EBITDA
- +5.6%
- EBIT
- +2.7%
- EPS
- +31.1%
- Free cash flow
- +0.1%
- Operating cash flow
- -1.2%
Forward estimates
Based on analyst estimates
- Revenue
- +1.5%
- EBITDA
- -7.6%
- EPS
- +23.6%
Three-year CAGR
- Revenue
- +5.5%
- EBITDA
- +8.7%
- EBIT
- +14.5%
- Net income
- +10.0%
- EPS
- +18.2%
- Free cash flow
- +10.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026